
European Mediscience Awards
Thursday 13 June 2024, Hotel InterContinental, London W1
Nominations open w/c 4 March 2024
About
About the Awards
Showcasing achievement and success in the UK and European healthcare, biotech, pharmaceutical and life sciences sectors
The European Mediscience Awards is now in its 22nd year, having been held every year since inception in 2002*. The event is the largest annual gathering of private and publicly quoted healthcare, biotech and life sciences companies in Europe. Bringing together the best of European mediscience companies to celebrate achievement and recognise success, it is the must-attend event for anybody working in this sector.
Each year sees the attendance of over 500 quoted and private UK and European life sciences companies and their corporate advisers, analysts, fund managers, commentators and peers. The event is sold out from one year to the next.
The European Mediscience Awards 2023 will take place on Thursday 15 June at the Hotel InterContinental, London, W1.
*with the exception of 2020 when we were unable to hold a live event due to COVID-19, but instead held a successful digital campaign.
Contact us
Sponsors
HSBC Innovation Banking provides commercial banking services, expertise and insights to the technology, life science and healthcare, private equity and venture capital industries. HSBC Innovation Banking is a subsidiary of HSBC Group, benefiting from its stability, strong credit rating and international reach to help fuel its growth.
Mainline sponsor:
HSBC Innovation Banking provides commercial banking services, expertise and insights to the technology, life science and healthcare, private equity and venture capital industries. HSBC Innovation Banking is a subsidiary of HSBC Group, benefiting from its stability, strong credit rating and international reach to help fuel its growth.

ICR Consilium is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. ICR Consilium's team, based in Europe and the US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision-makers and executives on critical communications programs, international media management, transactions and healthcare stakeholder challenges.
We work in partnership with our clients to translate complex healthcare situations into meaningful communications programmes that deliver sustained results, inspire action and build value. ICR Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
For more information, please see

ICR Consilium is a global leader in financial and corporate communications and investor relations focused on the healthcare sector. ICR Consilium's team, based in Europe and the US, provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision-makers and executives on critical communications programs, international media management, transactions and healthcare stakeholder challenges.
We work in partnership with our clients to translate complex healthcare situations into meaningful communications programmes that deliver sustained results, inspire action and build value. ICR Consilium has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
For more information, please see
FTI Consulting has built an unrivalled, global strategic communications offering to life science and healthcare companies. Our large team of life sciences and healthcare specialists has the breadth and depth of experience, in pharmaceuticals, biotech, medical devices, digital health and healthcare services, to help you ensure that the right message reaches the right audience at the right time.
We take a holistic view, helping clients, ranging from top-10 global pharmaceutical and medical device companies to small start-ups, to develop and defend their reputations; seek to attract and retain the best talent; navigate and inform health and policy agendas; and steady themselves for moments of change or periods of growth.
Whether you need support for capital markets transactions or fundraisings, digital and social media strategies to meet growing sector demand; internal change communication after transactions; market preparedness and product launch communications; crisis preparedness or response, clinical and regulatory milestone communications; corporate messaging or public affairs support, FTI has the expertise and capabilities to help you.
www.fticonsulting-emea.com/industries/healthcare-and-life-sciences
FTI Consulting has built an unrivalled, global strategic communications offering to life science and healthcare companies. Our large team of life sciences and healthcare specialists has the breadth and depth of experience, in pharmaceuticals, biotech, medical devices, digital health and healthcare services, to help you ensure that the right message reaches the right audience at the right time.
We take a holistic view, helping clients, ranging from top-10 global pharmaceutical and medical device companies to small start-ups, to develop and defend their reputations; seek to attract and retain the best talent; navigate and inform health and policy agendas; and steady themselves for moments of change or periods of growth.
Whether you need support for capital markets transactions or fundraisings, digital and social media strategies to meet growing sector demand; internal change communication after transactions; market preparedness and product launch communications; crisis preparedness or response, clinical and regulatory milestone communications; corporate messaging or public affairs support, FTI has the expertise and capabilities to help you.
www.fticonsulting-emea.com/industries/healthcare-and-life-sciences
MC Services is an international public relations and investor relations firm specializing in communications for the life sciences and healthcare sectors. With a strong team of advisors in science, finance, media communications and extensive industry experience, MC Services is a leading Life Sciences agency in Europe.
MC Services’ long-standing clients include international public and private companies, as well as venture capital and investment firms. Established for many years as a link between the healthcare industry and the financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services has offices in Munich, Düsseldorf, Berlin, London and Boston.
MC Services is an international public relations and investor relations firm specializing in communications for the life sciences and healthcare sectors. With a strong team of advisors in science, finance, media communications and extensive industry experience, MC Services is a leading Life Sciences agency in Europe.
MC Services’ long-standing clients include international public and private companies, as well as venture capital and investment firms. Established for many years as a link between the healthcare industry and the financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services has offices in Munich, Düsseldorf, Berlin, London and Boston.

MEDISTRAVA Consulting is an international healthcare advisory and strategic communications group, partnering with innovative biopharma companies and leading life science VCs.
We are a cross-functional group of experts offering best-in-class solutions designed to maximise corporate and asset value along the full development journey from discovery to product launch and beyond, including.
- Strategic Corporate, Scientific/Clinical and Investor Communications
- Equity Story Development
- Media Relations and Reputation Management
- Commercial Opportunity Assessment, Analytics & Development Strategy
- Scientific Narrative Development and Evidence Generation/Endorsement
- Market Access, Pricing & Health Economics and Outcomes Research
We are part of Inizio, a global commercialisation platform that unlocks, activates and optimises value for pharma and biopharma at each pivotal moment.

MEDISTRAVA Consulting is an international healthcare advisory and strategic communications group, partnering with innovative biopharma companies and leading life science VCs.
We are a cross-functional group of experts offering best-in-class solutions designed to maximise corporate and asset value along the full development journey from discovery to product launch and beyond, including.
- Strategic Corporate, Scientific/Clinical and Investor Communications
- Equity Story Development
- Media Relations and Reputation Management
- Commercial Opportunity Assessment, Analytics & Development Strategy
- Scientific Narrative Development and Evidence Generation/Endorsement
- Market Access, Pricing & Health Economics and Outcomes Research
We are part of Inizio, a global commercialisation platform that unlocks, activates and optimises value for pharma and biopharma at each pivotal moment.
Panmure Gordon, an innovative and forward-thinking investment bank, helps fast-growing corporate and institutional clients achieve their ambitions and has offices in London, Leeds and New York. It provides a full range of services including Corporate Broking, Corporate Advisory, Capital Raising, Investor Relations, Research, Sales, Sales Trading and Market Making.
Panmure Gordon, an innovative and forward-thinking investment bank, helps fast-growing corporate and institutional clients achieve their ambitions and has offices in London, Leeds and New York. It provides a full range of services including Corporate Broking, Corporate Advisory, Capital Raising, Investor Relations, Research, Sales, Sales Trading and Market Making.
Based in London and Dublin, Powerscourt is a multi-award winning communications consultancy. We specialise in advising clients on financial & capital markets communications, corporate communications & campaigns, political & regulatory affairs and crisis communications, backed by deep industry sector expertise.
Our healthcare team includes accomplished, agency professionals with former careers in both journalism and industry. Our 50+ years of healthcare sector experience have seen us represent companies investing in drug discovery, development and commercialisation, manufacturing and healthcare services from around the world.
Based in London and Dublin, Powerscourt is a multi-award winning communications consultancy. We specialise in advising clients on financial & capital markets communications, corporate communications & campaigns, political & regulatory affairs and crisis communications, backed by deep industry sector expertise.
Our healthcare team includes accomplished, agency professionals with former careers in both journalism and industry. Our 50+ years of healthcare sector experience have seen us represent companies investing in drug discovery, development and commercialisation, manufacturing and healthcare services from around the world.
SP Angel provides broking and corporate finance advisory services to over 60 companies across the Healthcare, Technology and Natural Resources sectors. Our Healthcare Team has a proven track record in raising funds for both private and quoted companies.
SP Angel provides broking and corporate finance advisory services to over 60 companies across the Healthcare, Technology and Natural Resources sectors. Our Healthcare Team has a proven track record in raising funds for both private and quoted companies.
WG Partners is a specialist life sciences boutique. We provide our clients with corporate advisory, M&A and capital raising services. In the last decade, we have completed transactions with a total value in excess of £8.2 billion. Our business is 100% owned by the partners who combine more than 250 years of relevant experience. We bring a truly international perspective, acting for corporate and institutional clients across the UK, Europe, USA, Asia and Australia.
WG Partners is a specialist life sciences boutique. We provide our clients with corporate advisory, M&A and capital raising services. In the last decade, we have completed transactions with a total value in excess of £8.2 billion. Our business is 100% owned by the partners who combine more than 250 years of relevant experience. We bring a truly international perspective, acting for corporate and institutional clients across the UK, Europe, USA, Asia and Australia.
Canary Wharf Group
Canary Wharf Group is the developer of the largest urban regeneration project in Europe.
We are a commercial and residential property company who, as owner, manager and developer, is responsible for the regeneration of 128 acres of the once-derelict Docklands district of East London. Our purpose is to transform urban space into extraordinary environment.
https://group.canarywharf.com/
Kadans
Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans is present on 25 campuses in 7 countries and is backed by AXA IM Alts. We build state-of-the-art facilities, tailored to meet your individual business needs. We build for innovation.
supported by:
Canary Wharf Group
Canary Wharf Group is the developer of the largest urban regeneration project in Europe.
We are a commercial and residential property company who, as owner, manager and developer, is responsible for the regeneration of 128 acres of the once-derelict Docklands district of East London. Our purpose is to transform urban space into extraordinary environment.
https://group.canarywharf.com/
Kadans
Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans is present on 25 campuses in 7 countries and is backed by AXA IM Alts. We build state-of-the-art facilities, tailored to meet your individual business needs. We build for innovation.
Awards
covering the period 1 April 2023 to 31 March 2024
Nominations open w/c 4 March 2024
Nominations overview
Click on each award to view more information
BEST COMMUNICATION AWARD
Sponsored by:

BEST COMMUNICATION AWARD
Sponsored by

Criteria
Successful communication is vital to the development of mediscience companies.
Newsflow, both good and bad, can have a significant effect on share prices, and the winner of this award will have demonstrated its ability to successfully communicate its investment message to its target audience.
2023 Winner

2023 Shortlist
- C4X Discovery Holdings plc
- Convatec Group plc
- Ergomed plc
- Ion Beam Applications SA
- Sectra AB
- Uniphar plc
BREAKTHROUGH OF THE YEAR AWARD
Sponsored by:
BREAKTHROUGH OF THE YEAR AWARD
Sponsored by
Criteria
The winner of this award will be the company or organisation which has achieved the most significant breakthrough during the period 1 April 2023 to 31 March 2024.
This breakthrough could be a new discovery, departure or breakthrough in technology, a significant positive change in its financial position, or other breakthrough which has added significantly to the company’s or organisation’s fortunes.
2023 Winner

2023 Shortlist
- argenx
- Calliditas Therapeutics AB
- Destiny Pharma plc
- Kooth plc
- Pharming Group N.V.
- Polarean Imaging plc
BEST TECHNOLOGY AWARD
Sponsored by:
BEST TECHNOLOGY AWARD
Sponsored by
Criteria
The technology that lies at the heart of this award does not have to be proven, but it will, in the eyes of the Voting Panel, be innovative, well funded, and capable of significant commercial success. The technology concerned could have been developed within the organisation or acquired.
2023 Winner
2023 Shortlist
- ANGLE plc
- Diaceutics plc
- hVIVO plc
- Newron Pharmaceuticals SpA
- Oxford BioDynamics plc
- Polarean Imaging plc
- Sequana Medical NV
THE EMERGING STAR AWARD
Sponsored by:
THE EMERGING STAR AWARD
Sponsored by
Criteria
The Emerging Star will be a private or young public mediscience company that has demonstrable credibility in terms of business model/strategy, management team and financing. The winner's focus on innovation will also be key, with its technology/IP capable of significant market impact or disruption.
The Emerging Star may not be able to demonstrate too much of a track record, but it will be judged against the demanding criteria that exist for its quoted company peers. The purpose of this award is to broaden knowledge, exchange ideas and help private businesses understand what could be required of them in the quoted company universe.
2023 Winner
2023 Shortlist
- Amphista Therapeutics Ltd
- Artios Pharma Ltd
- CDR-Life Inc.
- OMass Therapeutics Ltd
- Quell Therapeutics Ltd
- Smart Reporting GmbH
- SNIPR Biome
- Synaffix BV
MEDISCIENCE MEDIA COMMENTATOR OF THE YEAR AWARD
Sponsored by:
MEDISCIENCE MEDIA COMMENTATOR OF THE YEAR AWARD
Sponsored by
Criteria
This award recognises the importance of clear and concise commentary on the sector. It could be awarded to a journalist, a columnist, a specialist website or a team that is dedicated to providing sharp, perceptive and penetrating commentary about the sector.
In-depth knowledge of the sector is a given; the Voting Panel will be looking for excellence in the way that knowledge is communicated to the wider audience.
2023 Winner
2023 Shortlist
- John Carroll/Endpoints
- Jim Cornall/Labiotech
- Fierce Biotech Team
- Nuala Moran/BioWorld
- Alex Ralph/The Times
- Melanie Senior
CAPITAL MARKET TRANSACTION OF THE YEAR AWARD
Sponsored by:

CAPITAL MARKET TRANSACTION OF THE YEAR AWARD
Sponsored by

Criteria
This award recognises a significant capital market transaction during our period under review. The capital market transaction could be an IPO or a follow-on financing; it would be significant in scope and transformational in nature and would materially enhance the prospects for the business in the short, medium and long term.
In deciding the shortlist and eventual winner, the Voting Panel will take into account the amount raised, stock price performance and the quality of the share register.
2023 Winner
2023 Shortlist
- Abivax SA
- BenevolentAI SA
- BioInvent International AB
- GSK plc
- Novozymes A/S
- Valneva SE
MOST SIGNIFICANT CONTRIBUTION TO THE MEDISCIENCE SECTOR AWARD
Sponsored by:
MOST SIGNIFICANT CONTRIBUTION TO THE MEDISCIENCE SECTOR AWARD
Sponsored by
Criteria
The winner of this award could be an individual, a company, a government department, research council, etc. who has made the single, biggest, most significant contribution to the sector. Difficult to define, but the Voting Panel will be aware of, and make allowances for, this fact.
2023 Winner
UK BioIndustry Association (BIA)
2023 Shortlist
- Dr Melanie Lee CBE/LifeArc
- Anne Marden
- Novo Nordisk Foundation
- Jane Osbourn OBE/Alchemab Therapeutics Ltd
- Pascal Soriot/AstraZeneca plc
- UK BioIndustry Association (BIA)
CHIEF EXECUTIVE OF THE YEAR AWARD
Sponsored by:
CHIEF EXECUTIVE OF THE YEAR AWARD
Sponsored by
Criteria
The winner will be an individual who has demonstrated exceptional leadership qualities during the year under review. The creation of shareholder value through drive, vision and flair in taking his or her business forward are the qualities the Voting Panel is looking for. The winner will also have recognised the importance of developing a management team and workforce in supporting corporate success.
2023 Winner
Sijmen de Vries/Pharming Group N.V.
2023 Shortlist
- Yamin Khan/hVIVO plc
- Gunilla Osswald/Bioarctic AB
- Miroslav Reljanovic/Ergomed plc
- Adam Steensberg/Zealand Pharma A/S
- David Veitch/Basilea Pharmaceutica AG
- Sijmen de Vries/Pharming Group N.V.
COMPANY OF THE YEAR AWARD
Sponsored by:
COMPANY OF THE YEAR AWARD
Sponsored by
Criteria
The Company of the Year will already have gained recognition by analysts and investors.
It will be a well managed, soundly financed growth business with a well defined strategy to deliver its key financial, ethical and social ambitions. Put simply, the Voting Panel are not necessarily looking for the biggest, but they are looking for the best.
2023 Winner
2023 Shortlist
- argenx
- Ergomed plc
- Formycon AG
- hVIVO plc
- Novo Nordisk A/S
- Pharming Group N.V.
Voting panel
The Voting Panel will meet to discuss this year's nominations on Thursday 2 May 2024.
Members of the full 2024 Voting Panel will be announced on this page in due course.
Click below to see judges from past events.
The 2023 Voting Panel

The event
Sponsorship
Sponsorship opportunities sometimes become available, including sponsorship of an individual award, sponsorship of the official drinks reception or sponsorship of the menu. Sponsorship opportunities are, by their very nature, limited. Costs and availability on request.
Hosting a table
Reservations are available for tables of ten people. Numbers are strictly limited and reservations are taken on a first come, first served basis.
Advertising
Advertising in the digital brochure is welcomed and enables your key messages to reach a highly targeted audience. The digital event brochure is available to download on the night and contains details of the all nominees, the programme for the night and the menu. Uniquely, it also contains the names of all attendees, in alphabetical and table order. Thus it is widely used as a reference post event for up to a year afterwards.
Bespoke sponsorship opportunities
We offer a range of bespoke sponsorship packages, tailor made to suit your marketing objectives and budget. Further information on request.
Enquiries
For all enquiries relating to the European Mediscience Awards, please do get in touch with jo.thomas@ford-sinclair.co.uk.
Key details for guests
Date
Thursday 13 June 2024
Venue
Ballroom, Hotel InterContinental
One Hamilton Place
Park Lane
London W1J 7QY
Start time
6.00 p.m. – Drinks reception
7.30 p.m. – Dinner
9.15 p.m. – Awards
9.45 p.m. – After-dinner entertainment
12.00 midnight – Carriages
Dress code
Black Tie
Charity collection
A charity collection will be taken up during the course of the evening and the European Mediscience Awards team will be available throughout to accept contactless donations. Thank you in advance for your generosity.
Accommodation
Hotel InterContinental
Exclusive rates for bedrooms may be available for guests attending the event and further information will be available in due course.
Location
Latest media
Charity
A charity collection was held at the European Mediscience Awards 2023 in respect of two charities: bccs and Young Lives vs Cancer. The total amount raised which was split equally between these two charities was:
£10,832.24
bccs provides highly professional and well‑supported Social Workers and Counsellors to help children and young people who are in need.
bccs works in the East End of London and Essex with children, young people and their families and schools to help them overcome emotional difficulties, behavioural problems and their root causes. The prime focus of the work is to provide an early intervention service to enable them to address difficulties that may be impeding their educational, social and emotional development.
When a child is diagnosed with cancer it threatens everything, for them and their family.
At a time when they should be busy being children, enjoying the rollercoaster teenage years or finding their feet at Uni, life becomes full of fear. Families being torn apart, of overwhelming money worries, mental health stretched to breaking point, of having nowhere to turn, no one to talk to.
At Young Lives vs Cancer we get that and we do everything in our power so no family stands alone to cancer.
We know everyone’s different, so we work hard to make sure each family has what they need to get through.